Cardiovascular disease is the leading cause of death in women in the UK. Many women are unaware that their risk increases significantly after menopause. Hormonal changes, particularly declining oestrogen levels, influence cholesterol levels, blood vessels and metabolic health. Understanding these changes allows women and clinicians to take preventative steps that protect long-term heart health.
How Menopause Affects the Heart
Oestrogen plays an important role in maintaining healthy blood vessels and regulating cholesterol. During perimenopause and menopause, falling oestrogen levels can lead to changes that increase cardiovascular risk.
These include:
- Increased LDL cholesterol (“bad cholesterol”)
- Reduced HDL cholesterol (“good cholesterol”)
- Increased abdominal fat distribution
- Higher blood pressure
- Reduced insulin sensitivity
Together these changes can contribute to the development of atherosclerosis, the build-up of plaque inside arteries that can lead to heart attack or stroke.
Cardiovascular Risk After Menopause
Research suggests that women’s cardiovascular risk rises sharply after menopause, partly due to hormonal changes but also because of ageing and metabolic factors.
According to the British Heart Foundation, cardiovascular disease causes around one in four deaths in women in the UK [1]. Many women develop heart disease later than men, which historically led to the misconception that women are less affected.
However, symptoms can differ in women and may be less obvious, which makes awareness and early prevention essential.
Lifestyle Factors That Matter in Midlife
Several modifiable factors influence cardiovascular health during and after menopause.
Important areas to focus on include:
- Maintaining a healthy weight
- Regular physical activity including resistance training
- A balanced diet rich in vegetables, fibre and healthy fats
- Limiting alcohol intake
- Stopping smoking
- Managing stress and sleep quality
These steps support metabolic health and reduce the risk of heart disease.
The Role of Hormone Therapy
Menopausal hormone therapy (HRT or MHT) is not prescribed specifically to prevent cardiovascular disease. However, when started in appropriate women under 60 or within ten years of menopause onset, evidence suggests it does not increase cardiovascular risk and may provide metabolic benefits in some cases [2].
Decisions around hormone therapy should always involve individual assessment of risk factors and symptom burden.
Monitoring Your Cardiovascular Health
Midlife is an important opportunity to review cardiovascular risk.
Women should consider discussing with their clinician:
- Blood pressure monitoring
- Cholesterol testing
- Blood sugar or HbA1c testing
- Weight and waist circumference
- Family history of heart disease
Early detection and management can significantly reduce future risk.
Support at The Menopause Medic
At The Menopause Medic, we take a holistic approach to menopause care, supporting women with symptom management while also considering long-term health risks such as cardiovascular disease. Consultations are available in Berkhamsted and St Albans, as well as remotely across Hertfordshire and the UK.
References
[1] British Heart Foundation. Women and heart disease statistics.
https://www.bhf.org.uk/what-we-do/our-research/heart-statistics
[2] NICE. Menopause: diagnosis and management (NG23).
https://www.nice.org.uk/guidance/ng23
